ChemicalBook > CAS DataBase List > Clavulanic Acid DiMer IMpurity

Clavulanic Acid DiMer IMpurity

Product Name
Clavulanic Acid DiMer IMpurity
CAS No.
1260617-10-4
Chemical Name
Clavulanic Acid DiMer IMpurity
Synonyms
Clavulanic Impurity E;Clavulanate EP Impurity E;CLAVULANIC ACID EP IMPURITY E;Clavulanic Acid DiMer IMpurity;PotassiuM Clavunate IMpurity E;Potassium Clavulanate EP Impurity E;(2R,4R,Z)-2-(carboxymethyl)-5-(2-hydroxyethylidene);Potassium Clavulanate EP Impurity E Dipotassium Salt;Potassium Clavulanate EP Impurity E Dipotassium Salt;(2R,4R,5Z)-4-Carboxy-5-(2-hydroxyethylidene)-3-[[(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]-2-oxazolidineacetic Acid
CBNumber
CB82551533
Molecular Formula
C16H18N2O10
Formula Weight
398.32
MOL File
1260617-10-4.mol
More
Less

Clavulanic Acid DiMer IMpurity Property

Boiling point:
898.5±65.0 °C(Predicted)
Density 
1.75±0.1 g/cm3(Predicted)
pka
3.37±0.40(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Clavulanic Acid DiMer IMpurity Chemical Properties,Usage,Production

Uses

An impurity of Clavulanic Acid (C563750).

Clavulanic Acid DiMer IMpurity Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Clavulanic Acid DiMer IMpurity Suppliers

Pharma Affiliates
Tel
--
Fax
--
Email
@pharmaffiliates.com
Country
India
ProdList
6754
Advantage
58
Pharmaffiliates Analytics and Synthetics P. Ltd
Tel
--
Fax
--
Email
mktg@pharmaffiliates.com
Country
India
ProdList
6739
Advantage
58

1260617-10-4, Clavulanic Acid DiMer IMpurityRelated Search:


  • Clavulanic Acid DiMer IMpurity
  • (2R,4R,5Z)-4-Carboxy-5-(2-hydroxyethylidene)-3-[[(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]-2-oxazolidineacetic Acid
  • PotassiuM Clavunate IMpurity E
  • Clavulanate EP Impurity E
  • Clavulanic Impurity E
  • (2R,4R,Z)-2-(carboxymethyl)-5-(2-hydroxyethylidene)
  • Potassium Clavulanate EP Impurity E
  • 2-Oxazolidineacetic acid, 4-carboxy-5-(2-hydroxyethylidene)-3-[[(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]-, (2R,4R,5Z)-
  • CLAVULANIC ACID EP IMPURITY E
  • (2R,4R,5Z)-2-(Carboxymethyl)-5-(2-hydroxyethylidene)-3-[[(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabibyclo[3.2.0]hept-2-yl]carbonyl]oxazolidine-4-carboxylic Acid
  • (2R,4R,5Z)-2-(carboxymethyl)-5-(2-hydroxyethylidene)-3-[[(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]oxazolidine-4-carboxylic acid,
  • (2R,4R,Z)-2-(Carboxymethyl)-5-(2-hydroxyethylidene)-3-((2R,5R,Z)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carbonyl)oxazolidine-4-carboxylic acid (Clavulanic acid Impurity)
  • Potassium Clavulanate EP Impurity E Dipotassium Salt
  • Potassium Clavulanate EP Impurity E Dipotassium Salt
  • 1260617-10-4
  • Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
  • Heterocycles
  • Impurities
  • Intermediates & Fine Chemicals
  • Pharmaceuticals